Condition
Immune Tolerance clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Immune Tolerance clinical trials that are recruiting, at sites in 3 countries (most in United States (3), Switzerland (1), Turkey (Türkiye) (1)). By phase: Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Immune Tolerance clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tregs and miRNAs in Breast Milk: See if breast milk miRNAs influence infant immune cells and food tolerance | — | Istanbul and 1 other locations | Recruiting | Aug 4, 2026 |
| How a mother's immune system accepts pregnancy in the first trimester | — | Basel | Recruiting | Dec 22, 2025 |
| Train the immune system to accept a living-donor liver so you may stop lifelong anti-rejection drugs | Phase 1/2 | Los Angeles, California | Recruiting | Dec 8, 2025 |
| Kidney transplant with donor vertebral body marrow to promote engraftment | Phase 1 | Palo Alto, California and 1 other locations | Recruiting | Sep 30, 2020 |
| Eliminating immunosuppressive drugs in kidney transplant recipients using blood stem cell transplantation. | Phase 1 | Palo Alto, California | Recruiting | Jul 19, 2018 |
All recruiting trials (5)
-
Tregs and miRNAs in Breast Milk: See if breast milk miRNAs influence infant immune cells and food tolerance
This observational study tests whether immune-regulating miRNAs in breast milk relate to the development of infant food tolerance via regulatory T cells.
-
How a mother's immune system accepts pregnancy in the first trimester
We will test how the immune system changes in the first trimester in people undergoing IVF to see which immune patterns support implantation and help prevent early miscarriage.
-
Train the immune system to accept a living-donor liver so you may stop lifelong anti-rejection drugs
This test gives donor stem cells plus a short conditioning treatment to people with HLA-matched living-donor liver transplants to see if they can safely stop long-term immunosuppressive drugs.
-
Kidney transplant with donor vertebral body marrow to promote engraftment
This study tests whether giving bone marrow cells from the donor at the time of a deceased donor kidney transplant is safe and feasible in adults with end-stage kidney disease.
-
Eliminating immunosuppressive drugs in kidney transplant recipients using blood stem cell transplantation.
This study is testing whether kidney transplant patients can safely stop taking their immunosuppressive drugs by using a special treatment with blood stem cells.
Related topics
Quick answers
How many Immune Tolerance clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Switzerland (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.